Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adena Pepich

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|February 15, 2021
MYCN Function in Neuroblastoma DevelopmentJörg Otte, Cecilia Dyberg, Adena Pepich, et al.
Cell Death & Disease|April 19, 2025
Targeted inhibition of WIP1 and histone H3K27 demethylase activity synergistically suppresses neuroblastoma growthDiana Treis, Kristina Ihrmark Lundberg, Nicola Bell, et al.
Cell Death & Disease|April 24, 2026
Uncovering a role for METTL13 in malignant transformation of human hematopoietic stem cells and in the progression of pediatric leukemiaSabina Enlund, Chae-Eun Lim, Isabella Hoang, et al.
Cancer Letters|September 22, 2024
The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastomaAdena Pepich, Conny Tümmler, Sara Abu Ajamieh, et al.
JCI Insight|February 15, 2024
Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signatureShenglin Mei, Adele M Alchahin, Bethel Tesfai Embaie, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|February 15, 2021
MYCN Function in Neuroblastoma DevelopmentJörg Otte, Cecilia Dyberg, Adena Pepich, et al.
Cell Death & Disease|April 19, 2025
Targeted inhibition of WIP1 and histone H3K27 demethylase activity synergistically suppresses neuroblastoma growthDiana Treis, Kristina Ihrmark Lundberg, Nicola Bell, et al.
Cell Death & Disease|April 24, 2026
Uncovering a role for METTL13 in malignant transformation of human hematopoietic stem cells and in the progression of pediatric leukemiaSabina Enlund, Chae-Eun Lim, Isabella Hoang, et al.
Cancer Letters|September 22, 2024
The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastomaAdena Pepich, Conny Tümmler, Sara Abu Ajamieh, et al.
JCI Insight|February 15, 2024
Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signatureShenglin Mei, Adele M Alchahin, Bethel Tesfai Embaie, et al.
Pageof 1